272 related articles for article (PubMed ID: 23131904)
21. Characteristics and spectrum of BRCA1 and BRCA2 mutations in 3,922 Korean patients with breast and ovarian cancer.
Kim H; Cho DY; Choi DH; Choi SY; Shin I; Park W; Huh SJ; Han SH; Lee MH; Ahn SH; Son BH; Kim SW; ; Haffty BG
Breast Cancer Res Treat; 2012 Aug; 134(3):1315-26. PubMed ID: 22798144
[TBL] [Abstract][Full Text] [Related]
22. Prevalence and type of BRCA mutations in Hispanics undergoing genetic cancer risk assessment in the southwestern United States: a report from the Clinical Cancer Genetics Community Research Network.
Weitzel JN; Clague J; Martir-Negron A; Ogaz R; Herzog J; Ricker C; Jungbluth C; Cina C; Duncan P; Unzeitig G; Saldivar JS; Beattie M; Feldman N; Sand S; Port D; Barragan DI; John EM; Neuhausen SL; Larson GP
J Clin Oncol; 2013 Jan; 31(2):210-6. PubMed ID: 23233716
[TBL] [Abstract][Full Text] [Related]
23. BRCA mutations and survival in breast cancer: an updated systematic review and meta-analysis.
Zhu Y; Wu J; Zhang C; Sun S; Zhang J; Liu W; Huang J; Zhang Z
Oncotarget; 2016 Oct; 7(43):70113-70127. PubMed ID: 27659521
[TBL] [Abstract][Full Text] [Related]
24. Association between family history, mutation locations, and prevalence of BRCA1 or 2 mutations in ovarian cancer patients.
Singer CF; Tan YY; Muhr D; Rappaport C; Gschwantler-Kaulich D; Grimm C; Polterauer S; Pfeiler G; Berger A; Tea MM
Cancer Med; 2019 Apr; 8(4):1875-1881. PubMed ID: 30821131
[TBL] [Abstract][Full Text] [Related]
25. Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: US Preventive Services Task Force Recommendation Statement.
; Owens DK; Davidson KW; Krist AH; Barry MJ; Cabana M; Caughey AB; Doubeni CA; Epling JW; Kubik M; Landefeld CS; Mangione CM; Pbert L; Silverstein M; Simon MA; Tseng CW; Wong JB
JAMA; 2019 Aug; 322(7):652-665. PubMed ID: 31429903
[TBL] [Abstract][Full Text] [Related]
26. Correlation between the risk of ovarian cancer and BRCA recurrent pathogenic variants in Japan.
Sekine M; Enomoto T; Arai M; Yokoyama S; Nomura H; Nishino K; Ikeuchi T; Kuriyama Y; Nakamura S;
J Hum Genet; 2022 May; 67(5):267-272. PubMed ID: 34983974
[TBL] [Abstract][Full Text] [Related]
27. Prevalence of Hispanic BRCA1 and BRCA2 mutations among hereditary breast and ovarian cancer patients from Brazil reveals differences among Latin American populations.
Alemar B; Herzog J; Brinckmann Oliveira Netto C; Artigalás O; Schwartz IVD; Matzenbacher Bittar C; Ashton-Prolla P; Weitzel JN
Cancer Genet; 2016 Sep; 209(9):417-422. PubMed ID: 27425403
[TBL] [Abstract][Full Text] [Related]
28. [Clinical and molecular diagnosis of inherited breast-ovarian cancer].
Chompret A
J Gynecol Obstet Biol Reprod (Paris); 2003 Apr; 32(2):101-19. PubMed ID: 12717301
[TBL] [Abstract][Full Text] [Related]
29. Childhood cancer in families with and without BRCA1 or BRCA2 mutations ascertained at a high-risk breast cancer clinic.
Brooks GA; Stopfer JE; Erlichman J; Davidson R; Nathanson KL; Domchek SM
Cancer Biol Ther; 2006 Sep; 5(9):1098-102. PubMed ID: 16931905
[TBL] [Abstract][Full Text] [Related]
30. Multigene panel testing in unselected Israeli breast cancer cases: mutational spectrum and use of BRCA1/2 mutation prediction algorithms.
Bernstein-Molho R; Singer A; Laitman Y; Netzer I; Zalmanoviz S; Friedman E
Breast Cancer Res Treat; 2019 Jul; 176(1):165-170. PubMed ID: 30980208
[TBL] [Abstract][Full Text] [Related]
31. An unusual BRCA mutation distribution in a high risk cancer genetics clinic.
Nelson-Moseke AC; Jeter JM; Cui H; Roe DJ; Chambers SK; Laukaitis CM
Fam Cancer; 2013 Mar; 12(1):83-7. PubMed ID: 23179792
[TBL] [Abstract][Full Text] [Related]
32. SEOM clinical guidelines in Hereditary Breast and ovarian cancer.
Llort G; Chirivella I; Morales R; Serrano R; Sanchez AB; Teulé A; Lastra E; Brunet J; Balmaña J; Graña B;
Clin Transl Oncol; 2015 Dec; 17(12):956-61. PubMed ID: 26669313
[TBL] [Abstract][Full Text] [Related]
33. Frequency of mutations in BRCA genes and other candidate genes in high-risk probands or probands with breast or ovarian cancer in the Czech Republic.
Riedlova P; Janoutova J; Hermanova B
Mol Biol Rep; 2020 Apr; 47(4):2763-2769. PubMed ID: 32180084
[TBL] [Abstract][Full Text] [Related]
34. Preliminary results of targeted sequencing of
Saied MH; Elkaffash D; Fadl R; Haleem RA; Refeat A; Ibrahim I; Tahoun M; Elkayal A; Tayae E
Mol Med Rep; 2021 Sep; 24(3):. PubMed ID: 34296289
[TBL] [Abstract][Full Text] [Related]
35. Mutation analysis of BRCA1 and BRCA2 from 793 Korean patients with sporadic breast cancer.
Han SH; Lee KR; Lee DG; Kim BY; Lee KE; Chung WS
Clin Genet; 2006 Dec; 70(6):496-501. PubMed ID: 17100994
[TBL] [Abstract][Full Text] [Related]
36. Subsequent breast and high grade serous carcinomas after risk-reducing salpingo-oophorectomy in BRCA mutation carriers and patients with history of breast cancer.
Straub MM; Podoll MB; David SN; Wiesner GL; Desouki MM
Ann Diagn Pathol; 2018 Oct; 36():28-30. PubMed ID: 30055521
[TBL] [Abstract][Full Text] [Related]
37. BRCA1 and BRCA2 genetic testing in Italian breast and/or ovarian cancer families: mutation spectrum and prevalence and analysis of mutation prediction models.
Capalbo C; Ricevuto E; Vestri A; Ristori E; Sidoni T; Buffone O; Adamo B; Cortesi E; Marchetti P; Scambia G; Tomao S; Rinaldi C; Zani M; Ferraro S; Frati L; Screpanti I; Gulino A; Giannini G
Ann Oncol; 2006 Jun; 17 Suppl 7():vii34-40. PubMed ID: 16760289
[TBL] [Abstract][Full Text] [Related]
38. BRCA1 and BRCA2 genetic test in high risk patients and families: counselling and management.
Marchina E; Fontana MG; Speziani M; Salvi A; Ricca G; Di Lorenzo D; Gervasi M; Caimi L; Barlati S
Oncol Rep; 2010 Dec; 24(6):1661-7. PubMed ID: 21042765
[TBL] [Abstract][Full Text] [Related]
39. Incidence of BRCA1 and BRCA2 mutations in young Korean breast cancer patients.
Choi DH; Lee MH; Bale AE; Carter D; Haffty BG
J Clin Oncol; 2004 May; 22(9):1638-45. PubMed ID: 15117986
[TBL] [Abstract][Full Text] [Related]
40. Prevalence of BRCA1/2 germline mutations in 21 401 families with breast and ovarian cancer.
Kast K; Rhiem K; Wappenschmidt B; Hahnen E; Hauke J; Bluemcke B; Zarghooni V; Herold N; Ditsch N; Kiechle M; Braun M; Fischer C; Dikow N; Schott S; Rahner N; Niederacher D; Fehm T; Gehrig A; Mueller-Reible C; Arnold N; Maass N; Borck G; de Gregorio N; Scholz C; Auber B; Varon-Manteeva R; Speiser D; Horvath J; Lichey N; Wimberger P; Stark S; Faust U; Weber BH; Emons G; Zachariae S; Meindl A; Schmutzler RK; Engel C;
J Med Genet; 2016 Jul; 53(7):465-71. PubMed ID: 26928436
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
